FDA Approves New Sweetener, Advantame

Statement of CSPI Senior Scientist Lisa Lefferts

May 21, 2014

CSPI will be carefully reviewing the studies on Advantame.

However, an initial concern is that in a key cancer study in mice, the number of mice that survived to the end of the study was below FDA's own scientific recommendations, and is therefore inadequate to provide confidence in the safety of a chemical likely to be consumed by millions of people.


Get Updates Via Email

Journalists can receive CSPI news releases via email.
Not a journalist?

Sign Up for Email Now



Subscribe Now

Subscribe Now »

Subscribe Today and Save!

In Recent Issues

Cover Story: 1 in 8: What You May Not Know About Breast Cancer

Special Feature: Soy Oh Soy: Is It Really Bad For You?

Brand-Name Rating: Pasta Sauce

Subscribe Now

Request permission to reuse content

The use of information from this site for commercial purposes is strictly prohibited without written permission from CSPI.